PAIN — Vector Science and Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- CA$295.37m
- CA$294.16m
Annual cashflow statement for Vector Science and Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | fx Final | fx Final | fx Final | fx Final |
| Net Income/Starting Line | -0.006 | -0.065 | -0.034 | -0.037 | -0.085 |
| Non-Cash Items | 0 | 0.036 | 0 | — | — |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.006 | 0.002 | -0.001 | 0.009 | -0.009 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | 0 | -0.026 | -0.035 | -0.027 | -0.094 |
| Financing Cash Flow Items | -0.008 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 0.092 | 0.155 | 0 | — | — |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.092 | 0.128 | -0.035 | -0.027 | -0.094 |